Eli Lilly and Co
Can AI outperform doctors? Experts weigh the pros and cons
Cravetiger | Moment | Getty Images You may already be familiar with AI taking notes in your doctor’s office, or being used to help book appointments or analyze medical images. But some experts believe consumers should be using AI even more to help understand their health. “People should be using AI much more than they […]
Read More
Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs
Pharma thinks it’s found the next frontier in preventing heart attacks. Novartis, Amgen and Eli Lilly are among the drugmakers betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology. All three of the pharmaceutical giants are in late-stage trials to test whether drugs that cut Lp(a) […]
Read More
WHCD shooting, DOJ ends Powell probe, Musk vs. Altman and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Good morning. We have a big week ahead of us: In addition to earnings reports from key automakers and five of the “Magnificent Seven,” the Federal Reserve will make its next monetary policy decision and the trial between Elon Musk and Sam […]
Read More
Cramer’s week ahead: Record highs meet a pivotal week for tech earnings
Key Points CNBC’s Jim Cramer said the market has become a “beast”, driven by a powerful rally in data center and AI-related stocks. He then turned to the week ahead, where a packed slate of tech earnings will test whether the surge can continue or if expectations have gotten too high. CNBC’s Jim Cramer said […]
Read More
Stocks making the biggest moves midday: Intel, AMD, Charter, Hims & Hers, Eli Lilly and more
Check out the companies making the biggest moves in midday trading: Comcast , Charter Communications — The NBCUniversal parent tumbled nearly 8% after a Deutsche Bank downgrade to hold from buy. Analysts at the bank said that, “there’s visibility into a return to sustainable revenue, EBITDA, and [free cash flow] growth; we do not expect […]
Read More
European stocks fall as ceasefire optimism fades; Novo jumps after Lilly weight loss pill prescription data
A bear statue stands outside the Frankfurt Stock Exchange on April 7, 2025 in Frankfurt, Germany. Florian Wiegand | Getty Images European stock markets finished lower on Friday, as uncertainty over U.S.-Iran peace talks weighed on investor sentiment. The pan-European Stoxx 600 closed the day down 0.6%, with most regional sectors and major bourses in […]
Read More
Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment
Roche reported falling sales in the first three months of the year, as the strength of the Swiss franc and generic competition for some of its older drugs weighed on the drugmaker. First-quarter sales came in at 14.7 billion Swiss francs ($18.7 billion), down 5% year-on-year — but up 6% on a constant currency basis. […]
Read More
Step aside Tesla, BYD: Japanese carmakers deepen their hold on India’s auto market with hybrids
Hello, this is Priyanka Salve, writing to you from Singapore. Welcome to the latest edition of “Inside India“ — your one-stop destination for stories and developments from the world’s fastest growing large economy. Indian consumers’ desire to shift away from gasoline-based cars should have been Tesla and BYD’s moment to shine in the world’s third-largest auto market. […]
Read More
Amazon launches GLP-1 weight loss program, promising ‘fast, convenient’ access
Amazon GLP-1 treatment Source: Amazon Inc. Amazon is pushing deeper into the booming weight loss market, unveiling Tuesday a new program that aims to simplify access to popular GLP-1 treatments. The company said its primary care arm, Amazon One Medical, is launching a GLP-1 management program that integrates obesity treatment into routine care. The offering […]
Read More
Jim Cramer warns against chasing ‘parabolic’ stocks and says there’s opportunity in overlooked names instead
Key Points CNBC’s Jim Cramer cautioned against chasing “parabolic” tech and AI stocks, warning those trades can quickly reverse. He emphasized the importance of finding opportunities in overlooked names and the need for diversification. CNBC’s Jim Cramer said Monday he’s wary of investors piling into the market’s hottest trades, arguing that chasing “parabolic” moves often […]
Read More